| 标题 |
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled, double-blind, phase III clinical trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:American Heart Journal 作者:Di Xiao; Changwei Liu; Leng Ni; Wei Ye; Zhihua Rong; et al 出版日期:2022-08-21 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)